Clinical Trial Update: Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.

View source ↗

Summary

A real-world study evaluating patient outcomes and experiences with ribociclib in breast cancer is currently recruiting, sponsored by Novartis Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Status: RECRUITING